Fresenius Medical Care

Being able to participate more in social life and a better quality of life – these are some of the effects reported by dialysis patients treated on hemodiafiltration, as seen in the CONVINCE Study. When researchers initiated the CONVINCE Study, they aimed to quantify the benefits patients could receive from high-dose hemodiafiltration (HDF) compared to the standard treatment, hemodialysis. The results were not only promising regarding HDF as a treatment method for reducing mortality rates, but they also highlighted the unique role that patient-reported outcomes (PROs) can play in medical studies for people with kidney disease and others. Krister Cromm, Fresenius Medical Care’s Director of Person-Centered Outcomes Research, played a critical role in gathering and analyzing data from the CONVINCE Study. According to Cromm, PROs provide valuable insights into how someone feels living with a chronic disease, leading to meaningful conversations about optimizing care and choosing the right treatment. “The CONVINCE study showed that it’s possible to achieve a higher quality of life and live longer with hemodiafiltration. For example, the study showed higher social participation, better physical function, better cognitive function and lower pain interference of participants. These are very promising prospects and a light at the end of the tunnel for many patients.” Read the full article to learn how these findings are shaping patient-centered care and improving outcomes in kidney health: https://lnkd.in/degPSfgE #ProudtobeFME #TogetherAhead #Healthcare #Dialysis

Celebrating a Milestone in Clinical Education: NephroCare Academy has issued its one millionth Certificate of Achievement! 🎉 Congratulations to Danuta Marianowska, Head of Nursing Care Delivery International from the Gniezno clinic in Poland, as the proud recipient of this milestone certificate. With 29 years of experience in dialysis nursing, Danuta exemplifies the commitment to professional growth and quality patient care that NephroCare Academy fosters. At the Gniezno clinic in Poland, she and her team of eleven colleagues care for 75 hemodialysis patients, regularly accessing and benefiting from the training courses. The NephroCare Academy, a Fresenius Medical Care business provider available to all clinical employees across Europe, the Middle East, and Africa, offers a diverse range of learning modalities tailored to meet every nurse’s needs. This enables them to develop skills, acquire new competencies, and perform procedures while following best practices in the care of hemodialysis patients. These initiatives contribute to improving the quality of patient care and ensuring staff comfort and safety. This milestone is more than a number – it represents the collective stories towards personal and professional growth in our industry. Here's to many more as we continue our journey towards providing the highest quality of patient care! #NephroCareAcademy #NursingEducation #TogetherAhead #ProudToBeFME

Celebrating Pride Month at Fresenius Medical Care! 🌈 This June, Fresenius Medical Care proudly celebrates Pride Month, honoring diversity, encouraging acceptance, and fostering inclusion through educational materials and impactful events with internal and external speakers. Yesterday, our employee Ryan Smith talked about their personal journey working at Fresenius Medical Care as a leader who identifies as a member of the LGBTQ+ community. “I try to remember that I don't have to define myself as being one, static thing. Identity is an evolution, and each experience brings me a greater understanding of who I am and who I want to be,” said Ryan. Pride Month is a vital time to celebrate and support the LGBTQ+ community. We're proud to have a global LGBTQIA and Allies Employee Resource Group (ERG) dedicated to championing diversity, educating allies, and advocating for LGBTQ+ rights. By showing our support, we help create a more inclusive and accepting world. Together, we make a difference! #PrideMonth #FreseniusMedicalCare #LGBTQIA #Inclusion #Diversity #Authenticity #ProudToBeFME

Making better choices about health and health care requires the best possible evidence. With more digital data available for research and better tools to analyze it, researchers can now quickly and efficiently produce the scientific evidence needed to improve patient care. This new way of generating evidence involves working together across different areas, locations, and stages of product development. While it takes effort to implement, it can significantly improve patient outcomes and the health care industry. In the new episode of GMO Dialogues, Dr. Manuela Stauss-Grabo, Head of Global Biomedical Evidence Generation, discuss the importance of this approach in advancing health care. Watch the full episode and discover how these innovative approaches are changing the life of our patients: https://lnkd.in/dxgPkeqG #DataAnalytics #HealthcareInnovation #GMOdialogues

Announcement 📢: Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations through virtual power purchase agreements (vPPAs) with wind and solar energy developers in Germany and the U.S. Projects are expected to feed around 580 gigawatt hours of renewable energy into the grid, which equals up to 46 percent of FME's most recently reported global consumption. This is an important milestone for strategic sustainability goal to achieve climate-neutrality by 2040. "The commitment to sustainability is firmly anchored in our corporate mission with the objective to become carbon neutral in our operations by 2040," says CEO Helen Giza. "The successful execution of the agreements is an important milestone and brings us closer to this goal."   Read more in the press release here: https://lnkd.in/dMVv3vwV   #Announcement #SustainabilityJourney #Sustainability #ProudtobeFME #TogetherAhead

Fresenius Medical Care is best-in-class in its ESG Risk Rating in our industry group and is included in Morningstar Sustainalytics 2024 ESG Top-Rated Companies list! Managing sustainability risks and seizing opportunities is an important part of our strategy and governance. Morningstar Sustainalytics has been rating our progress in managing risks and we are proud to announce that we again improved our ESG Risk Rating.   As of May 2024, Fresenius Medical Care AG received an ESG Risk Rating of 12.2 from Sustainalytics and was assessed to be at low risk of experiencing material financial impacts from ESG factors.   Learn more about our progress in our Sustainability Highlights overview and our Sustainability Report below.   #SustainabilityJourney #ESG #Rating #TogetherAhead #ProudToBeFME

From June 6-9, millions of EU citizens will come together to elect the new European parliament. Every election is a privilege as it gives us the opportunity to vote and to take action in expressing what we believe and how we want to build up our future and the society we live in. This election is very important not only for the future of Europe and the EU citizens, but also for upholding the values we cherish.   At Fresenius Medical Care, we are proud to share a vision that unites our colleagues around the globe with respect and tolerance. Our roots are built upon the very values of European democracy which are Human dignity, freedom, democracy, equality, rule of law, and human rights.   At our core is a culture of openness, diversity, and tolerance. It’s right there in our name – care. Standing up for these values is of utmost importance in the coming European Election.   Our message is simple: Participate actively in the upcoming elections. Never take democracy for granted. Make a statement for the values that have made Europe strong and that continue to be the foundation of our values in an ever-changing world.   Find more information on how to #UseYourVote here: https://lnkd.in/d24hHYbd   #TogetherAhead #ProudToBeFME

Join us at the Asian Pacific Congress of Nephrology #APCN2024 and Korean Society of Nephrology #KSN next week from 13 – 16 June in Seoul, Korea!   💡 At our industrial symposium - Meet our international keynote speakers (Prof. Bernard Canaud & Yeoung Jee Cho) and learn more about the benefits of #HighVolumeHDF in-centre dialysis therapy and empowering patients on their kidney care journeys at home to improve patient outcomes. 💡 At our booth D2 - get more insights on the shift of standard kidney care to individualized care for patients undergoing dialysis at home and in-center dialysis. Look forward to meeting you at APCN x KSN 2024!   Register here! https://lnkd.in/g6TnQ5PE   #APCN2024 #APCN #KSN #APCNxKSN 

Exciting news 📢: As of June 1, 2024, we proudly welcomed Jörg Häring to our Management Board as the new Global Head of Legal, Compliance and Human Resources. He is also assuming the role as Labor Director. Congratulations Jörg and welcome to Fresenius Medical Care – we are looking forward to having you, and your international experience and expertise on board! Please read the initial announcement here: https://lnkd.in/d6BKJPWQ #Announcement #ManagementBoard #ProudtobeFME #TogetherAhead

Happy Pride Month! At Fresenius Medical Care, we believe in creating an inclusive environment where every individual feels valued and respected. Throughout this month, we’ll host events and activities designed to foster understanding, support, and celebrate our LGBTQ+ colleagues. 🏳️🌈 We’re kicking off with several exciting events for our employees. Highlights include a presentation by Gina Battye, CEO of Psychological Safety Institute on the Importance of Bringing Your Authentic Self to Work, along with talks from our internal speakers and engaging panel discussions. 🏳️🌈 We’re also proud to announce that our LGBTQIA and Allies Employee Resource Group (ERG) is going global, welcoming everyone to champion LGBTQ+ rights in our workplace. Curious to learn more? Visit our website below to meet our inspiring colleagues who champion bottom-up inclusivity and drive efforts that foster a culture of support, belonging, and celebration at Fresenius Medical Care. #Pride #PrideMonth #LGBTQ #ProudToBeFME #TogetherAhead